Cargando…
Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study
Background and Objectives: Intravenous recombinant tissue plasminogen activator (rt-PA) has been approved for acute ischemic stroke (AIS) within 3 h after onset and the treatment was then extended to 4.5 h. However, the Food and Drug Administration did not approve the indication in the expanded time...
Autores principales: | Chen, Yu-Wei, Sung, Sheng-Feng, Chen, Chih-Hung, Tang, Sung-Chun, Tsai, Li-Kai, Lin, Huey-Juan, Huang, Hung-Yu, Po, Helen L., Sun, Yu, Chen, Po-Lin, Chan, Lung, Wei, Cheng-Yu, Lee, Jiunn-Tay, Hsieh, Cheng-Yang, Lin, Yung-Yang, Yeh, Shoou-Jeng, Lien, Li-Ming, Jeng, Jiann-Shing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803783/ https://www.ncbi.nlm.nih.gov/pubmed/31681138 http://dx.doi.org/10.3389/fneur.2019.01038 |
Ejemplares similares
-
Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3–4.5 h
por: Chen, Chih-Hao, et al.
Publicado: (2022) -
Low Cholesterol Levels Increase Symptomatic Intracranial Hemorrhage Rates After Intravenous Thrombolysis: A Multicenter Cohort Validation Study
por: Lin, Sheng-Feng, et al.
Publicado: (2019) -
Triglyceride-Glucose Index and Intravenous Thrombolysis Outcomes for Acute Ischemic Stroke: A Multicenter Prospective–Cohort Study
por: Lin, Sheng-Feng, et al.
Publicado: (2022) -
Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021) -
Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)